Nichols named LLS chief medical officer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Gwen Nichols was named chief medical officer of the Leukemia & Lymphoma Society.

A physician and scientific researcher, Nichols has advanced cures for cancers through a unique combination of clinical, academic and pharmaceutical experience. AS CSO, she will oversee LLS’s scientific research portfolio, patient access services and policy and advocacy initiatives.

Most recently, Nichols was oncology site head of the Roche Translational Clinical Research Center, where she worked to develop new cancer therapies, translating them from the laboratory to clinical trials. Prior to joining Roche in 2007, Nichols was at Columbia University for more than ten years, where she served as the director of the Hematologic Malignancies Program.

Table of Contents

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

Login